- Drug delivery
- Drug development
- Drug discovery
- Analgesia & Pain
- Musculoskeletal system
- Cardiovascular diseases and circulatory system
- Genetic and rare diseases
- Infectious diseases
- Gynaecology and obstetrics
- Ophtalmology and optometry
- Blood and lymphatic system
- Central nervous system
- Respiratory and pulmonary system
- Metabolic disorders / Endocrinology
In Novartis, we reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
We develop and produce innovative medicines to address patient needs in disease areas where our experience and knowledge have the potential to produce transformative treatments. We work in the areas of: oncology, infectious diseases, ophthalmology, cardiovascular and metabolism, neuroscience, immunology, hepatology and dermatology, and respiratory.
In 2018, our dedicated researchers made progress on a number of fronts, especially in neuroscience, oncology and ophthalmology. They also embraced new technology as we expanded data science and digital initiatives while acquiring key assets, such as gene therapies, to bolster our pipeline of unconventional medicines.